The human 5-HT 6 receptor (5-HT 6 R) is one of the latest cloned receptors among the known 5-HT receptors. Its abundant distribution in the limbic region, which participates in the control of mood and emotion and is involved in nervous system diseases such as depression and Alzheimer disease, has caused it to generate much interest. However, the cellular mechanisms of 5-HT 6 R are poorly understood. In the present study we found, using a yeast two-hybrid assay, that the carboxyl-terminal region of 5-HT 6 R interacts with the Fyn-tyrosine kinase. We also determined using a glutathione S-transferase pulldown assay that this interaction was mediated through the SH3 domain of Fyn and confirmed this by co-immunoprecipitation assays in two different transfected cell lines as well as in adult rat brains. Immunocyto(histo)chemistry also showed prominent co-localization between 5-HT 6 R and Fyn in transfected cells and a similar distribution between 5-HT 6 R and Fyn in the rat brain. Based on this interaction, we further examined the modulation of 5-HT 6 R by Fyn and vice versa. In addition, we demonstrated that the activation of 5-HT 6 R activated the extracellular signalregulated kinase1/2 via an Fyn-dependent pathway. These findings suggest that Fyn may play an important role in 5-HT 6 Rmediated signaling pathways in the central nervous system.
The human 5-HT 6 receptor (5-HT 6 R) is one of the latest cloned receptors among the known 5-HT receptors. Its abundant distribution in the limbic region, which participates in the control of mood and emotion and is involved in nervous system diseases such as depression and Alzheimer disease, has caused it to generate much interest. However, the cellular mechanisms of 5-HT 6 R are poorly understood. In the present study we found, using a yeast two-hybrid assay, that the carboxyl-terminal region of 5-HT 6 R interacts with the Fyn-tyrosine kinase. We also determined using a glutathione S-transferase pulldown assay that this interaction was mediated through the SH3 domain of Fyn and confirmed this by co-immunoprecipitation assays in two different transfected cell lines as well as in adult rat brains. Immunocyto(histo)chemistry also showed prominent co-localization between 5-HT 6 R and Fyn in transfected cells and a similar distribution between 5-HT 6 R and Fyn in the rat brain. Based on this interaction, we further examined the modulation of 5-HT 6 R by Fyn and vice versa. In addition, we demonstrated that the activation of 5-HT 6 R activated the extracellular signalregulated kinase1/2 via an Fyn-dependent pathway. These findings suggest that Fyn may play an important role in 5-HT 6 Rmediated signaling pathways in the central nervous system.
Serotonin (5-hydroxytryptamine (5-HT)
2 ) is an important neurotransmitter that is found in both the central and peripheral nervous systems as well as in non-neuronal systems such as the gut, lymphoid system, and blood (1-3). 5-HT mediates its diverse physiological responses through at least 16 different receptors which are subdivided into 7 distinct subfamilies, the 5-HT [1] [2] [3] [4] [5] [6] [7] receptors. With the exception of the 5-HT 3 receptor that is a ligand-gated ion channel, all other 5-HT receptors are members of the G-protein-coupled receptor superfamily (4) . Among them, the 5-HT 6 receptor (5-HT 6 R) is one of the most recently discovered 5-HT receptors and, like the 5-HT 4 and 5-HT 7 receptors, is positively coupled to adenylate cyclase via G s proteins (5) (6) (7) . The human 5-HT 6 R was first isolated by Kohen et al. (5) , and the receptor has been reported to be broadly expressed in the brain, especially in the striatum, nucleus accumbens, hippocampus, and cortex (8 -11) . 5-HT 6 R has also shown a high affinity for antipsychotic compounds (clozapine and loxapine) as well as a wide range of tricyclic antidepressants (amoxipine, clomipramine, and amitryptyline) (12, 13) . The abundant distribution in limbic region, which participates in the control of mood and emotion, and high affinity for antipsychotic and antidepressant compounds implies its significant roles in the CNS. Several functional studies have also implicated 5-HT 6 R in learning and memory disorders (14, 15) , depression (16, 17) , and Alzheimer disease (18, 19) . However, the cellular mechanisms responsible for 5-HT 6 R-mediated physiological responses are poorly elucidated. Therefore, to identify the function of 5-HT 6 R and its cellular mechanisms in the CNS, we employed a yeast two-hybrid screen system on a human brain cDNA library, with the carboxyl terminus of 5-HT 6 R as bait and found that the Fyn-tyrosine kinase is bound to 5-HT 6 R.
Fyn is a member of the Src family of non-receptor proteintyrosine kinases (20) and is expressed to a high degree in neurons, glia, and oligodendrocyte (21) (22) (23) . Recently, the physiological importance of Fyn has been suggested in the CNS. Using fyn Ϫ mutant mice, it was shown that a Fyn deficiency results in various neuronal defects, including defective long-term potentiation, impaired spatial memory, increased fearfulness, and ethanol sensitivity (24 -26) . It is also reported that Fyn is involved in Alzheimer disease through the modulation of microtubule-associated tau and amyloid ␤ (27) (28) (29) (30) and is required during brain development (24, 31, 32) . The kinase activity of Fyn is regulated by the two best-characterized tyrosine phosphorylation sites, Tyr-420 and Tyr-531. The Tyr-420 site undergoes autophosphorylation, which activates full kinase activity, but phosphorylation of the Tyr-531 site inhibits kinase activity through an intramolecular interaction between phos-pho-Tyr-531 and the SH2 domain, which stabilizes a non-catalytic conformation (33, 34) . The SH3 domain of Fyn (Fyn-SH3 domain), consisting of ϳ60 residues, is the best-characterized domain for Fyn-mediated protein-protein interaction (33, 35) . Interestingly, the carboxyl-terminal region of 5-HT 6 R contains the conserved PXhPXR amino acid sequence (X, any amino acid; h, hydrophobic amino acid), which is known as a class II ligand for the Fyn-SH3 domain (35) .
In the present study we demonstrate that the carboxyl terminus of 5-HT 6 R is bound with Fyn, in particular the Fyn-SH3 domain, and that the Tyr-420 site of Fyn kinase is functionally regulated by the activation of 5-HT 6 R. Furthermore, we examined the downstream signaling modulated by the activation of 5-HT 6 R and found that the activation of the extracellular signal-regulated kinase1/2 (ERK1/2) via a Fyn-dependent pathway is one of targets in 5-HT 6 R-mediated signaling pathways.
EXPERIMENTAL PROCEDURES
Plasmid Constructs-Full-length non-or HA-tagged human 5-HT 6 R cDNA in pcDNA3.1 were purchased from UMR cDNA Resource Center (Miner Circle Rolla, MO). cDNA fragments encoding the carboxyl terminus (CT) of 5-HT 6 R were subcloned (primer; Fw, 5Ј-CCG GAA TTC ATG CCA CTC TTC ATG-3Ј, Rv, 5Ј-CGC GGA TCC TCA GTT CGT GGG-3Ј) into the EcoRI/BamHI sites of Gal4 DNA binding domain vector, pGBKT7 (BD Biosciences, Clontech, Palo Alto, CA). A human brain cDNA library in the GAL4 activation domain vector pACT2 was purchased from BD Biosciences. Full-length Fyn was subcloned (primer; Fw, 5Ј-CCG GAA TTC ACC ATG GGC TGT GTG C-3Ј, Rv, 5Ј-CGC GGA TCC TTA CAG GTT TTC ACC-3Ј) into the EcoRI/BamHI sites of pcDNA3.1 (Invitrogen) from the human brain cDNA library. His-CT plasmid was constructed by cloning the CT region (amino acids Pro 321 -Asn 440 ) from pcDNA3.1/5-HT 6 R into the BamHI/ EcoRI sites of pET28a (ϩ) (Novagen, Madison, WI). GST-SH2 and GST-SH3 plasmids were constructed by cloning the SH2 (amino acids Trp 149 -Cys 246 ) and SH3 (amino acids Thr 82 -Ser 143 ) domains from pcDNA3.1/Fyn into the BamHI/EcoRI sites of the pGEX4T-1 vector (Amersham Biosciences). Myctagged SH3 plasmid was constructed by recloning from pGEX4T-1/SH3 into the BamHI/EcoRI sites of pCMV-Tag 3B vector. Plasmid constructs were generated by standard PCR amplification methods, and the subcloned DNA fragments were systematically checked by sequencing.
Yeast Two-hybrid Assay-The yeast two-hybrid assay was performed using the Matchmaker GAL4 two-hybrid system 3 (Clontech). The bait plasmid, pGBKT7/CT of 5-HT 6 R, was stably expressed in yeast strain AH109 and did not have a selftranscriptional activity. The prey plasmid, human brain cDNA library/pACT2, was transformed into yeast strain Y187. The corresponding AH109 yeast strains (MAT␣) were mated with the Y187 yeast strain (MATa). The diploid colonies were plated on a nutritionally selective plate deficient in adenine, histidine, leucine, and tryptophan (ϪAde, ϪHis, ϪLeu, ϪTrp) to screen the library. False positives were eliminated using two reporters, ADE2 and HIS3, and MEL1-encoding ␤-galactosidase was assayed on 5-bromo-4-chloro-3-indolyl-␣-D-galactopyranoside (X-␣-gal) indicator plates. Doubly positive clones were isolated and characterized by DNA sequencing. ␤-Galactosidase activity for a yeast two-hybrid assay was measured using a ␤-galactosidase colony-lift filter assay in accordance with the manufacturer's instructions (Clontech).
Expression of Recombinant Proteins and Pulldown AssayHis-CT plasmid was transformed into the bacterial host strain BL21 (DE3) and induced by adding 0.5 mM isopropyl 1-thio-␤-D-galactopyranoside at 25°C during midlog phase. GST, GST-SH2, and GST-SH3 plasmids were also expressed under the same conditions except with the addition of 0.2 mM isopropyl 1-thio-␤-D-galactopyranoside. The cells were sonicated in lysis buffer (1ϫ PBS, pH 7.4, 1 mM dithiothreitol, 0.01% Triton X-100, and protease inhibitor mixture). His-CT proteins were purified using His⅐Bind column (Novagen). GST, GST-SH2, and GST-SH3 proteins were immobilized by glutathione gel, and GST pulldown assays were performed using the Profound Pull-down GST Protein:Protein Interaction kit (Pierce). Bound His-CT proteins were eluted by boiling for 10 min at 95°C in SDS sample buffer followed by immunoblotting with anti-GST (1:5000; Novagen) and anti-His 6 antibodies (1:5000; Roche Diagnostics).
For His-mediated pulldown assays using rat brain lysates, brain lysates were prepared from age-and weight-controlled adult male Sprague-Dawley rats (60 -70 days old, 230 -260 g). Rat brain was homogenized in 10 ml of lysis buffer A (1ϫ PBS, pH 7.4, 0.32 mM sucrose, 10 mM dithiothreitol, 1 mM EDTA, and protease inhibitor mixture). The homogenate was centrifuged at 1000 ϫ g and 4°C for 10 min, and the supernatants were further centrifuged at 20,000 ϫ g for 1 h to yield a crude membrane pellet. The pellet was resuspended in lysis buffer A and solubilized with 1% Triton X-100 on ice for 1 h. After centrifugation at 20,000 ϫ g and 4°C for 30 min, the supernatant was collected. Separately, purified His-CT proteins were immobilized using a His⅐Bind-agarose resin, and the His-mediated pulldown assay was performed using the Profound Pull-down Poly-His Protein:Protein Interaction kit (Pierce). Immobilized His-CT proteins were incubated with the prepared brain lysates. Bound rat brain proteins were eluted by boiling for 10 min at 95°C in SDS sample buffer followed by immunoblotting with anti-Fyn (1:2000; Upstate Biotechnology Inc., Lake Placid, NY) and anti-His 6 antibodies (1:5000).
Cell Culture and Transfection-HEK293 cells were grown in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, penicillin (100 units/ml), and streptomycin (100 g/ml) at 37°C in a humidified atmosphere of 5% CO 2 and 95% air. Cells were transiently transfected with human 5-HT 6 R and G␣ 15 G-protein in the absence or presence of Fyn using Lipofectamine 2000 (Invitrogen). Naïve Chinese hamster ovary (CHO) cells (CHO/K1) and 5-HT 6 R stably expressed CHO (CHO/5-HT 6 R) cells (CHO/5-HT 6 R), which were kindly provided by Dr. M. Teitler (Albany Medical College, Albany, NY), were grown in F-12/Dulbecco's modified Eagle's medium (1:1) supplemented with 10% fetal bovine serum, penicillin (100 units/ml), and streptomycin (100 g/ml). G418 (400 g/ml) was additionally used in CHO/5-HT 6 R cells. For transient transfection, cells were cultured in 100-mm dishes and transfected with Fyn, Myc-SH3, or HA-5-HT 6 R using PolyFect transfection reagent (Qiagen, Valencia, CA).
Co-immunoprecipitation-HEK293 or CHO/K1 cells were gently lysed with lysis buffer B (1ϫ PBS, pH 7.4, 10 mM dithiothreitol, 1 mM EDTA, 1% Triton X-100, and protease inhibitor mixture) for 30 min on ice and then centrifuged at 20,000 ϫ g and 4°C for 15 min, and the supernatant was collected. The soluble lysates were incubated with 4 g of anti-HA (Cell Signaling Technology, Beverly, MA) or anti-Fyn (Cell Signaling) antibodies for 6 h at 4°C and then with 50 l of ImmunoPure Immobilized Protein G Plus (Pierce) for 2 h at 4°C and washed 6 times. Immune complexes were eluted by boiling for 10 min at 95°C in SDS sample buffer followed by immunoblotting with anti-HA (1:1000) or anti-Fyn (1:1000) antibodies. For co-immunoprecipitation using rat brain lysates, brain lysates were prepared as described in His-mediated pulldown assays. The soluble lysates from rat brain were immunoprecipitated with 10 g of a specific antibody (anti-5-HT 6 R (GeneTex Inc., San Antonio, TX), anti-Fyn (Upstate), or control rabbit IgG antibodies) and 50 l of AminoLink Plus Coupling Gel from ProFound Mammalian Co-immunoprecipitation kit (Pierce) for 6 h or overnight at 4°C and washed five times. Immune complexes were eluted using IgG elution buffer (Pierce) or by boiling for 10 min at 95°C in SDS sample buffer, detected, and immunoblotted anti-Fyn (1:2000) .
Immunocyto(histo)chemistry-For immunocytochemistry, HEK293 or CHO/5-HT 6 R cells were grown on culture slides (BD Biosciences), fixed 24 h after transfection in 4% paraformaldehyde and PBS for 20 min at room temperature, washed 3 times in PBS, and preheated using antigen retrieval buffer (100 mM Tris-HCl and 5% (w/v) urea, pH 9.5). The cells were permeabilized with 0.2% Triton X-100 in PBS for 20 min, washed 3 times in PBS, and blocked with 3% bovine serum albumin in PBS for 1 h at room temperature. Then HEK293 cells were incubated for 6 h at 4°C with anti-HA (1:500; Cell Signaling) and anti-Fyn (1:500; Cell Signaling) antibodies, and CHO/5-HT 6 R cells were incubated overnight at 4°C with anti-5-HT 6 R (1:50; GeneTex) and anti-Fyn (1:50; Upstate) antibodies. Next, the cells were washed 3 times and incubated with rabbit IgG (FITC) and mouse IgG (rhodamine) secondary antibodies (1:400; Abcam, Cambridge, UK) for 1.5 h at room temperature. The cells were washed three times, mounted on glass slides using CRYSTAL/MOUNT TM (Biomeda Corp., Foster City, CA), and viewed on a confocal LSM 510 laser scanning microscope (Zeiss, Göttingen, Germany).
For immunohistochemistry, adult male Sprague-Dawley rats were perfused with saline and then fixed with 4% paraformaldehyde in PBS. Brains were sectioned at 10 m in a cryostat at Ϫ20°C. Sections were collected on a coated glass slide and dried at room temperature before being returned to Ϫ70°C for storage. Slides were post-fixed with acetone for 30 min on ice. Slides were processed as described above, under "Immunocyto(histo)chemistry," except that slices were incubated with horseradish peroxidase-conjugated secondary antibody (1:200; anti-mouse or anti-rabbit; Jackson ImmunoResearch, West Grove, PA) and developed with diaminobenzidine (Roche Diagnostics).
Assay of 5-HT 6 R Activity Using a FDSS6000 System-For assay of 5-HT 6 R activity, we used a FDSS6000 96-well fluorescence plate reader. HEK293 cells seeded at a density 5 ϫ 10 6 cells in 100-mm dishes were transiently transfected with human 5-HT 6 R and G␣ 15 protein in the absence or presence of Fyn using Lipofectamine 2000 (Invitrogen). 24 h after transfection cells were seeded into 96-well black wall clear-bottom plates at a density of 60,000 -80,000 cells/well, and 5-HT 6 R activity was measured the next day. The cells were loaded with 5 M fluo-4/AM and 0.001% Pluronic F-127 (Molecular Probes, Eugene, OR) and incubated for 60 min at 37°C in a HEPESbuffered solution (115 mM NaCl, 5.4 mM KCl, 0.8 mM MgCl 2 , 20 mM HEPES, and 13.8 mM glucose, pH 7.4). Cells were washed 3 times with the HEPES buffer and remained in a volume of 80 l per well. During the whole procedure, cells were washed using the BIO-TEK 96-well washer (BIO-TEK instruments, Winooski, VT). After at least 10 min of incubation time, cells were assayed with the FDSS6000 system. After determination of a short base line, 10 M or various indicated doses of 5-HT were added to HEK293 cells, and the calcium response was measured at 480 nm. All data were collected and analyzed using the FDSS6000 and the related software (Hamamatsu Photonics, Japan).
Surface Biotinylation-After 24 h of transfection, biotinylation of cell surface proteins was performed using Pinpoint Cell Surface Protein Isolation kit (Pierce) according to the manufacturer's instructions. HEK293 cells grown on 100-mm plates were washed 3 times with ice-cold PBS and incubated with 1 mg/ml EZ-link Sulfo-NHS-SS-biotin in PBS for 30 min at 4°C. The cells were rinsed in Tris-buffered saline to quench and remove free biotin reagents and lysed in lysis buffer (Pierce). After centrifugation, supernatants were incubated with 50 l of a 50% slurry of Immobilized NeutrAvidin for 3 h at 4°C. Reaction complexes were washed three times with wash buffer (Pierce) and two more times with PBS, and then biotinylated proteins were eluted by boiling in SDS sample buffer followed by immunoblotting with an anti-HA antibody (1:1000; Cell Signaling) to detect 5-HT 6 R, anti-Fyn (1:1000; Cell Signaling), and anti-␤-actin (1:5000; Sigma) antibodies.
Fyn Kinase Activity Assay-CHO/5-HT 6 R cells were gently lysed with lysis buffer B containing 2 mM Na 3 VO 4 and 10 mM Na 4 P 2 O 7 . Total protein concentration was determined by the modified Bradford method (Bio-Rad). Equal amounts of lysates were immunoprecipitated with 4 g of anti-Fyn (Santa Cruz Biotechnology, Santa Cruz, CA) and 25 l of AminoLink Plus Coupling Gel (Pierce) followed by immunoblotting with antiFyn (1:200) and anti-pY416 Src (1:3000; Upstate) that crossreact with phospho-Tyr-420 Fyn.
Phospho-ERK1/2 Assay-After CHO/5-HT 6 R cells were kept in serum-free Dulbecco's modified Eagle's medium for 16 h, the cells were treated with 5-HT or pretreated with the indicated drugs and lysed in lysis buffer B containing 2 mM Na 3 VO 4 , 10 mM Na 4 P 2 O 7 , and 10 mM NaF. Equal amounts of lysate were prepared and immunoblotted with anti-ERK1/2 (1:500; Cell Signaling) and anti-phospho-ERK1/2 (1:1000; Cell Signaling) antibodies.
Western Blot Analysis-After SDS-PAGE, the proteins were transferred to a polyvinylidene difluoride membrane (Bio-Rad), and the membrane was blocked with Tris-buffered saline containing 5% skim milk and 0.1% Tween 20 for 1.5 h at room temperature. After blocking, the membranes were incubated with the respective primary antibodies for 2 h at room temperature or overnight at 4°C. After three washes, the membranes were incubated with horseradish peroxidase-conjugated secondary antibodies (anti-mouse or anti-rabbit 1:15,000; Jackson ImmunoResearch, West Grove, PA) for 2 h at room temperature and visualized using the ECL kit (Millipore, Bedford, MA).
Statistical Analysis-The intensity of the bands was measured using the AlphaEase program (Version 5.1, Alpha Innotech, San Leandro, CA) and analyzed using the GraphPad Prism Version 4 program (GraphPad Software Inc., San Diego, CA). All numeric values are represented as the mean Ϯ S.E. The statistical significance of the data was determined using Student's unpaired t test. Significance was set at p Ͻ 0.05, and the values of P for significant differences are indicated in the text and figure legends.
RESULTS

Identification of Fyn as a 5-HT 6 R-binding Protein Using the
Yeast Two-hybrid System-To identify the function of 5-HT 6 R and its cellular mechanism in the CNS, we performed a yeast two-hybrid screen using the CT of human 5-HT 6 R as bait. After screening the human brain cDNA library, we identified that Fyn-tyrosine kinase interacted with the CT of 5-HT 6 R. To confirm this specific interaction, we carried out a yeast two-hybrid assay using CT cDNA (bait) transformed in the AH109 yeast strain and full-length Fyn cDNA (prey) transformed into the Y187 yeast strain as shown Fig. 1A . When both the AH109 and Y187 yeast strains were mated, a blue color was detected with the ␤-galactosidase colony-lift filter assay (Fig. 1B) , suggesting that the interaction between the CT of 5-HT 6 R and Fyn is positive.
Fyn Interacts with 5-HT 6 R in Vitro and in Vivo-First, the specificity of the interaction between the CT of 5-HT 6 R and Fyn, especially the Fyn-SH3 domain, was biochemically investigated using a GST pulldown assay. After GST, GST-SH2, and GST-SH3 were expressed in Escherichia coli ( Fig. 2A) , GST, GST-SH2, and GST-SH3 were immobilized by glutathione gel. A, after GST, GST-SH2, and GST-SH3 were expressed in E. coli, they were analyzed using 15% SDS-PAGE and immunoblotting (IB) with anti-GST antibody. B, His-tagged CT protein was expressed in E. coli, purified by His⅐Bind column, and detected using immunoblotting with an anti-His 6 antibody (left). Purified His-CT was incubated with immobilized GST (negative control), GST-SH2, or GST-SH3. The retained proteins were analyzed using immunoblotting with anti-His 6 antibody (right). C-D, in vivo co-immunoprecipitation (IP) assays in HEK293 and CHO/K-1 cells. Where specified, HEK293 (C) and CHO/K-1 (D) cells were transfected with HA-5-HT 6 R and HA-5-HT 6 R in the absence and presence of Fyn, respectively. After 24 h, the cells were lysed, and immunoprecipitation was carried out by using anti-HA or anti-Fyn antibodies. The immune complexes were then analyzed by 10% SDS-PAGE followed by immunoblotting with anti-HA and anti-Fyn antibodies. The proper expression of transiently transfected and endogenous proteins in cell lysates was identified by Western blot analysis with anti-HA or anti-Fyn antibodies. E, purified His-CT proteins were immobilized and incubated with rat whole brain lysates. The retained proteins were detected with anti-Fyn antibody. Fyn interacted with immobilized His-CT proteins (second lane) but not with the negative control, His⅐Bind-agarose resin (first lane). F, rat brain lysates were co-immunoprecipitated with control rabbit IgG, anti-5-HT 6 R, and anti-Fyn antibodies. Immune complexes and the cell lysates were analyzed by 10% SDS-PAGE followed by immunoblotting with an anti-Fyn antibody. The experiments shown in Fig. 2 were repeated in triplicate with similar results.
His 6 -tagged CT protein was incubated with the glutathione gel bound to GST, GST-SH2, or GST-SH3. Purified His-CT protein interacted with GST-SH3 but not GST or GST-SH2 (Fig.  2B) . These data indicate that the CT of 5-HT 6 R selectively interacts with the SH3 domain but not the SH2 domain of Fyn in vitro.
Second, we attempted to determine whether full-length 5-HT 6 R selectively binds to Fyn in mammalian cells using an in vivo co-immunoprecipitation assay. After full-length HAtagged 5-HT 6 R (HA-5-HT 6 R) was transiently transfected into HEK293 cells, cell lysates were prepared, immunoprecipitated with anti-HA antibodies, and subsequently immunoblotted with anti-Fyn antibodies. As shown in Fig. 2C , the transfected HA-5-HT 6 R was able to bind to endogenous Fyn (second lane) in the HEK293 cells, whereas no signal was detected from non-transfected cells (first lane). When co-immunoprecipitation was performed in reverse with anti-Fyn antibodies followed by immunoblotting with anti-HA antibodies, the result was the same (Fig. 2C, third lane) . We next examined whether this specific association between 5-HT 6 R and Fyn was also present in CHO/K-1 cell lines. After HA-5-HT 6 R and Fyn were transfected into CHO/K-1 cells, the immunoprecipitation was performed with either anti-HA or anti-Fyn antibodies. As shown in Fig. 2D , HA-5-HT 6 R was co-immunoprecipitated with both exogenous (second and third lanes) and endogenous Fyn (fourth lane), whereas no signal was detected in immunoprecipitates from non-transfected cells (first lane). These results suggest that the specific binding of 5-HT 6 R to Fyn occurs in mammalian cells.
Although the interaction between two proteins was validated in transfected mammalian cells, the association of two proteins in native tissues was still undetermined. We, therefore, examined the interaction between 5-HT 6 R and Fyn from rat brain lysates using His pulldown and co-immunoprecipitation assays. We first showed that purified His-CT proteins of 5-HT 6 R pulled down Fyn proteins from rat brain lysates, whereas there was no signal when non-immobilized resin was used (Fig. 2E) . The interaction between 5-HT 6 R and Fyn was next examined using a co-immunoprecipitation assay. The cell lysates from whole rat brain were prepared, immunoprecipitated with anti-5-HT 6 R or anti-Fyn antibodies, and subsequently immunoblotted with an anti-Fyn antibody. As shown in Fig. 2F , 5-HT 6 R selectively binds to endogenous Fyn (third lane) in the rat brain, whereas no signal was detected in immunoprecipitates from control IgG antibody (second lane). These results consistently show that 5-HT 6 R associates with Fyn in native tissues.
Co-localization and Immunohistochemistry of 5-HT 6 R and Fyn-A common requirement for specific physical and functional interaction between 5-HT 6 R and Fyn is that they must be positioned in close proximity. Therefore, we next determined whether both proteins are co-localized in the same cellular compartment in HEK293 cells and 5-HT 6 R stably expressed CHO (CHO/5-HT 6 R) cell lines, which were later used for functional assays of 5-HT 6 R and Fyn, respectively. First, HEK293 cells were transfected with HA-5-HT 6 R along with (Fig. 3B ) or without Fyn (Fig. 3A) . HA-5-HT 6 R was immunostained with mouse anti-HA and then rhodamine-conjugated secondary antibodies. Fyn was immunostained with rabbit anti-Fyn and then FITC-conjugated secondary antibodies. Immunofluorescence analysis using confocal microscopy revealed that both endogenous Fyn (Fig. 3A) and exogenous Fyn (Fig. 3B) were predominantly localized on intracellular membranes and were co-localized with HA-5-HT 6 R. These results suggest that 5-HT 6 R and Fyn co-localize in HEK293 cells.
The co-localization of 5-HT 6 R and Fyn was also evident in CHO/5-HT 6 R cells. CHO/5-HT 6 R cells were transiently transfected with Fyn. 5-HT 6 R was immunostained with rabbit anti-5-HT 6 R and FITC-conjugated secondary antibodies. Fyn was immunostained with mouse anti-Fyn and rhodamine-conjugated secondary antibodies. As shown in Fig. 3C , double immunofluorescence labeling also revealed the clear co-localization of 5-HT 6 R and Fyn in CHO/5-HT 6 R cells.
Immunohistochemistry was also performed to examine any relationship in the regional and cellular distributions of 5-HT 6 R and Fyn in the rat brain. As illustrated in Fig. 3D , we used anti-5-HT 6 R and anti-Fyn antibodies to map the regional expressions of 5-HT 6 R and Fyn, respectively, in coronal sections of adult rat brains. Use of anti-5-HT 6 R and anti-Fyn antibodies led to intensive staining in the cortex, hippocampus, and hypothalamus, suggesting similar expression profiles (Fig. 3D , middle panels). When immunohistochemical images from the hippocampal formation were magnified, both 5-HT 6 R (Fig. 3D , right upper panels) and Fyn (Fig. 3D , right lower panels) proteins were prominently expressed on cell bodies rather than on the nerve terminals of pyramidal neurons in the CA3 region of the hippocampus. 6 RBased on evidence for a physical interaction between 5-HT 6 R and Fyn, we next examined whether Fyn influences the activity of 5-HT 6 R or vice versa. First, we measured the activity of 5-HT 6 R using a FDSS6000 96-well fluorescence plate reader. Because the mammalian G proteins G␣ 15 and G␣ 16 couple a wide variety of receptors to phospholipase C and induce mobilization of intracellular calcium stores (36), we setup a G␣ 15 / FDSS6000 system to measure the calcium response from the G␣ 15 -coupled human 5-HT 6 R in HEK293 cells (Fig. 4A) . When HEK293 cells were transiently transfected with 5-HT 6 R and G␣ 15 , 10 M 5-HT induced a calcium increase through the activation of 5-HT 6 R. This 5-HT-induced calcium response was significantly increased by the expression of Fyn compared with cells expressing only a control vector. This Fyn-mediated increase of 5-HT 6 R activity was also observed with a full dose of 5-HT. As shown in Fig. 4B , concentration-response curves to 5-HT showed an increased maximum with Fyn expression without any significant change in apparent 5-HT 6 R affinity. The calculated EC 50 values were 3.9 Ϯ 0.3 nM in the absence and 3.2 Ϯ 0.5 nM in the presence of Fyn (n ϭ 3, p ϭ 0.29). We next attempted to examine how the overexpression of Fyn increases 5-HT 6 R activity without changing the affinity for the receptor. We quantified the expression of 5-HT 6 R in the absence and presence of Fyn by using surface biotinylation experiments. As shown in Fig. 4C , HEK293 cells cotransfected with HA-5-HT 6 R and Fyn exhibited more 5-HT 6 R at the cell surface than cells transfected only with HA-5-HT 6 R (151.3 Ϯ 18.3% of control, n ϭ 3, p Ͻ 0.05). There was no difference in the level of total expression for 5-HT 6 R proteins (90.7 Ϯ 17.4% of control, n ϭ 3, p ϭ 0.408).
The Expression of Fyn Increases the Activity of 5-HT
The Activation of 5-HT 6 R Increases Fyn PhosphorylationWe next examined whether the activation of 5-HT 6 R by 5-HT modulates Fyn kinase. Because Fyn kinase has been known to be autophosphorylated at the Tyr-420 site for full kinase activity (34), we examined Fyn kinase activity using anti-Fyn and anti-pY420 antibodies in CHO/5-HT 6 R cells. Based on preliminary dose-dependent experiments (data not shown), a concentration of 20 M 5-HT was chosen for the remaining experiments. After CHO/5-HT 6 R cells were kept in serum-free Dulbecco's modified Eagle's medium for 16 h, the cells were treated with 20 M 5-HT for 1 or 5 min, and Fyn was immunoprecipitated using anti-Fyn antibody. As shown in Fig. 4D , there was a significant increase in pY420-Fyn protein levels after a 5-min treatment (137.7 Ϯ 8.0% of control, n ϭ 3, p Ͻ 0.01), whereas the level of Fyn protein was constant.
To examine whether the increased phosphorylation at Tyr-420-Fyn by 5-HT is mediated through the interaction between 5-HT 6 R and Fyn, we interfered with the interaction by overexpression of the Fyn-SH3 domain in CHO/5-HT 6 R cells. This was done because a GST pulldown assay (Fig. 2B) provided that the Fyn-SH3 domain is the binding site interacted with the CT of 5-HT 6 R. As shown in Fig. 4E , 5-HT-induced Fyn activation was significantly reduced by the overexpression of the Fyn-SH3 domain (51.5 Ϯ 2.5% of control, n ϭ 3, p Ͻ 0.001). These results indicate that the functions of 5-HT 6 R and Fyn are reciprocally modulated through the specific interaction between the CT of 5-HT 6 R and the Fyn-SH3 domain.
Activation of ERK1/2 through 5-HT 6 R Is Dependent on FynRecent studies have reported that the 5-HT 4 and 5-HT 7 receptors, which couple to the heterotrimeric G-protein G s , produce Ras-dependent activation of ERK1/2 (37). We, therefore, examined whether human G s -coupled 5-HT 6 R also modulates ERK1/2 activity and, if this is the case, whether Fyn is involved in 5-HT 6 R-induced activation of ERK1/2. Fig. 5A shows the time course of activation of ERK1/2 by 20 M 5-HT in CHO/5-HT 6 R cells. The maximal activation of ERK1/2 appeared after 5 min, gradually decreased until 60 min, and returned to a basal level after a 120-min incubation. We further examined the detailed mechanism of activation of ERK1/2 in CHO/5-HT 6 R cells after a 5-min 5-HT treatment. First, to examine an involvement of Fyn in 5-HT 6 R-induced activation of ERK1/2, CHO/5-HT 6 R cells were pretreated with the Fyn inhibitor PP2. Pretreatment with PP2 for 25 min led to a significant decrease in activation of ERK1/2 by 5-HT without any effect from PP2 alone (54.9 Ϯ 5.4% of control, n ϭ 4, p Ͻ 0.001; Fig. 5B ). Because PP2 has also been known to inhibit Src-like tyrosine kinase, we cannot rule out any possibility for involvement of Src tyrosine kinase. Therefore, we tried to interfere in the interaction between 5-HT 6 R and Fyn by overexpression of the Fyn-SH3 domain, as we did in Fig.  4D . As shown in Fig. 5C , overexpression of the Fyn-SH3 domain significantly reduced activation of ERK1/2 by 5-HT (69.7 Ϯ 2.8% of control, n ϭ 3, p Ͻ 0.001). Second, we attempted to test the role of cAMP-dependent protein kinase (PKA) in the signaling pathway because 5-HT 6 R increases cAMP through release of GTP-bound G s protein, which then activates PKA (5-7). When CHO/5-HT 6 R cells were pretreated with the PKA inhibitor H89 (20 M) for 25 min, activation of ERK1/2 by 5-HT was partially but significantly reduced, as shown in Fig. 5D (89.3 Ϯ 2 .4% of control, n ϭ 3, p Ͻ 0.05). These results suggest that activation of ERK1/2 by 5-HT through 5-HT 6 R is mainly through Fyn-dependent as well as partial PKA-dependent pathways.
5-HT-induced Activation of ERK1/2 Is Dependent on Ras and
MEK but Not Rap1-Signaling pathways for activation of ERK1/2 also include the small GTPase Ras or Rap1-dependent pathways in the mammalian cells (38) . To examine whether activation of ERK1/2 by 5-HT 6 R depends on Ras or Rap1, CHO/5-HT 6 R cells were pretreated with the selective Ras inhibitor FTI277 or the selective Rap1 inhibitor GGTI298 for 24 h. As shown in Fig. 6A , pretreatment with the Ras inhibitor FTI277 (10 M) blocked 5-HT-induced activation of ERK1/2 (65.5 Ϯ 10.7% of control, n ϭ 3, p Ͻ 0.01). However, the Rap1 inhibitor GGTI298 (10 M) did not influence the 5-HT-induced activation of ERK1/2 (98.3 Ϯ 11.3% of control, n ϭ 3, Fig. 6B ). Mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (MEK) has also been known to play a central role in the classical signaling pathways from cell surface receptors to ERK1/2 (39) . Pretreatment with the selective MEK inhibitor PD98059 (10 M) for 20 min blocked activation of ERK1/2 by 5-HT (44.7 Ϯ 5.2% of control, n ϭ 3, p Ͻ 0.001, Fig. 6C ). Taken together, these results suggest that the 5-HT-induced activation of ERK1/2 is dependent on Ras and MEK but independent of Rap1.
DISCUSSION
In the present study we demonstrated a novel interaction between the carboxyl terminus of 5-HT 6 R and Fyn using a yeast two-hybrid assay and provided firm evidence in support of a critical role for Fyn in 5-HT 6 R-mediated signaling pathways using several assays, including GST or His pulldown, co-immunoprecipitation, immunocyto(histo)chemistry, and biochemical assays.
Based on the literature concerning the roles of 5-HT 6 R and Fyn in the CNS, 5-HT 6 R and Fyn have many similarities, such as involvement in brain development, learning and memory, fearfulness, and Alzheimer disease (14 -19, 24 -32, 40) . We, therefore, hypothesized that there is a functional relationship through the interaction between 5-HT 6 R and Fyn in the CNS and herein provided clear evidence for a direct and reciprocal functional interaction between 5-HT 6 R and Fyn. First, we found that Fyn acts as a 5-HT 6 R-binding protein using a yeast two-hybrid assay and that 5-HT 6 R and Fyn are present as a protein complex in transfected cells and adult rat brains using co-immunoprecipitation binding assays. The present study is the first report of a novel interaction between 5-HT 6 R and Fyn. Fyn possesses SH2 and SH3 domains that are involved in protein-protein interactions in its cellular signaling cascades (33) . The Fyn-SH3 domain binds specifically to both RXhPPhP (class I) and PXhPXR (class II) consensus sequences, whereas the Fyn-SH2 domain is best characterized to bind with pY(M/Y)XM (pY is phosphorylated Tyr) sequences (35) . Based on sequence searching, it is interesting that the CT region of 5-HT 6 R contains a conserved PXhPXR amino acid sequence, consistent with the class II ligand for the Fyn-SH3 domain. Using a GST pulldown assay, we demonstrated the selective interaction between the CT of 5-HT 6 R and the Fyn-SH3 domain, but not the SH2 domain (Fig. 2B) . However, these results cannot exclude an involvement of the Fyn SH2 domain in 5-HT 6 Rmediated signaling pathways. It might be possible for the Fyn SH2 domain to play indirect roles via interactions with known or unknown proteins that are modulated by the activation of 5-HT 6 R.
Second, co-localization assays confirmed that 5-HT 6 R and Fyn are positioned in close proximity, specifically co-localized on the cell surface and on intracellular membranes but not in the nucleus in mammalian cells. In addition, it was found that there was a high coincidence in the expression profiles of 5-HT 6 R and Fyn in adult rat brains using immunohistochemistry; both 5-HT 6 R and Fyn proteins were intensively stained in the cortex, hippocampus, and hypothalamus in a similar expression profile. These results support the notion that 5-HT 6 R is physically associated with Fyn in adult rat brains, potentially allowing for functional modulation between the proteins. It is of interest to compare the expression profiles in the hippocampus as shown in Fig. 3D . Along with the observation that the Fyn deficiency present in fyn Ϫ mutant mice results in various neuronal defects, including defective long-term potentiation, impaired spatial memory, and increased fearfulness (24, 25) , there has been increasing interest in the role of 5-HT 6 R in higher cognitive processes, such as memory (14, 17) . The third and last piece of evidence for the specific interaction comes from the functional assays for 5-HT 6 R and Fyn activity. Surprisingly, the activity of 5-HT 6 R and Fyn are reciprocally modulated; the expression of Fyn increased 5-HT 6 R activity by increasing the surface expression of HT 6 R, and the activation of 5-HT 6 R by 5-HT increased Fyn phosphorylation. Based on our results, we propose that 5-HT increased Fyn phosphorylation at the Tyr-420 site through an interaction between 5-HT 6 R and the Fyn-SH3 domain and that this step further activated ERK1/2 via Ras and MEK-dependent pathways. Stimulation of G s -coupled receptors leads to activation of adenylyl cyclase and a rapid increase in cAMP. The main target of cAMP is PKA, which has been proposed to play an essential role in the ERK1/2 cascade (37, 41). As a member of the G s -coupled receptors, the capability of 5-HT 4 and 5-HT 7 receptors to activate ERK1/2 was reported in mammalian cell lines (37) . The present study first demonstrates that, like 5-HT 4 and 5-HT 7 , 5-HT 6 R is also able to activate ERK1/2.
The significance of the present study not only lies in providing direct evidence for 5-HT 6 R-mediated activation of ERK1/2 but also in providing evidence for the specific role of Fyn through a direct interaction with 5-HT 6 R in 5-HT 6 R-mediated signaling pathways, especially in the ERK1/2 cascade. Although the specific involvement of Fyn in 5-HT 6 R-mediated activation of ERK1/2 was suggested from the experiments using the Fyn inhibitor PP2 and overexpression of the Fyn-SH3 domain to interfere with the interaction between 5-HT 6 R and the Fyn-SH3 domain, we cannot rule out any possibility of involvement of other Src family tyrosine kinases or cross-talk with receptor tyrosine kinases such as epidermal growth factor receptors. Our observation on the activation of ERK1/2 via 5-HT 6 R is very similar to the ones for 5-HT 4 and 5-HT 7 receptors described in detail in a previous study (37) . In both pathways the involvement of PKA was at least partially suggested in 5-HT-mediated activation of ERK1/2. Both studies suggest that activation of ERK1/2 through 5-HT 6 R or 5-HT 4 /5-HT 7 receptors is dependent on Ras and MEK but independent of Rap1. These observations raise a possible involvement of Fyn in 5-HT 4 -and 5-HT 7 receptor-mediated activation of ERK1/2. However, the direct interaction of the Fyn-SH3 domain with the 5-HT 4 or 5-HT 7 receptors is unlikely to be involved because 5-HT 4 and 5-HT 7 receptors do not contain a conserved PXhPXR amino acid sequence (class II) as a ligand for the Fyn-SH3 domain. Because many studies reported that ERK1/2 can be activated by a direct/ indirect interaction with Src family tyrosine kinases or crosstalk with tyrosine kinase pathways (42) (43) (44) , it is of interest to elucidate any involvement and role of Fyn in 5-HT 4 and 5-HT 7 receptor-mediated signaling pathways.
One important question that should be addressed is how overexpression of Fyn increases 5-HT 6 R activity without changing its affinity for the receptor. In a previous study it was reported that activation of rat 5-HT 6 R rapidly induced receptor desensitization in HEK293 cells (45) . It might be possible that overexpression of Fyn helps 5-HT 6 R to express in more stabilized forms on the cell membrane and to prevent receptor desensitization or internalization. In the present study we clearly demonstrated that Fyn increased the surface expression of 5-HT 6 R, which played a potentiating role for Fyn on 5-HT 6 R function. However, further investigation is necessary to understand the exact mechanism of Fyn in the trafficking of 5-HT 6 R and in the modulation of 5-HT 6 R activity.
In conclusion, we demonstrated the specific role of Fyn in the modulation of 5-HT 6 R activity and its cellular signaling pathways via a direct interaction. The physiological significance of the observed interaction between 5-HT 6 R and Fyn is unknown at this point. In aplysia, G s -coupled 5-HT receptors have been implicated in ERK activation and long-term potentiation induction (46, 47) . Like the role of 5-HT receptors in aplysia, 5-HT 6 R-Fyn protein complexes may play important roles in mammalian neuronal functions such as memory formation, depression, and Alzheimer disease. Therefore, our results provide novel evidence at the cellular level and will have importance implications for 5-HT 6 R-and Fyn-mediated functions in the CNS.
